Basic Information
Kato Pharmaceuticals, as a clinical-stage biopharmaceutical company, is committed to developing novel therapies for eye-related diseases such as diabetic retinopathy (a leading cause of adult blindness).
Kato Pharmaceuticals LLC
California,United States of America
unclear
January 01, 2011
contact@katopharma.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios